Figures & data
Table 1 The dosing interval of antitumor necrosis factor (TNF) agents is determined by several factors, such as half-life, affinity for TNF, and protein stability
Table 2 PURSUIT-SC study results
Table 3 PURSUIT-Maintenance trial results
Table 4 Induction treatment with golimumab consists of two injections: 200 mg and 100 mg at week 0 and week 2, respectively